{"store":{"baseInfo":{"podcastTitle":"The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast","slug":"jimmyrq","podcastDescription":"The Pharm So Hard Podcast is a show focused primarily on emergency medicine and hospital pharmacy related topics. Episodes range from 5-30 minutes depending on the topic and guest speakers. The goal is to disseminate information in bite-sized episodes from experts in the field of acute care and hospital pharmacy sub-specialties.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/18130768/avatars-000688425426-5pwyrm-original.jpg","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/18130768/avatars-000688425426-5pwyrm-original_1200x628.jpg?s=26f3c6fa0fae4490783a216d4691f8f8&e=jpg","podcastUrl":"https://jimmyrq.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/jimmyrq/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pw/pbblog-j9fca-114a750?from=usersite","removePodbeanBranding":"yes","brandingLogo":"http://imglogo.podbean.com/companyLogo/18136751/2024-03-13_113402e53bf7d7-0d9c-2893-4d93-ca2ba83dd560_y88er.jpg","timeZone":{"timeZoneId":15,"gmtAdjustment":"GMT-05:00","useDaylightTime":1,"value":-5,"text":"(GMT-05:00) Eastern Time (US & Canada)","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"America/New_York"},"podcastDownloads":null,"totalEpisodes":125,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":false,"author":"Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP","enableEngagementStats":true,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-j9fca-114a750-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/us/podcast/the-pharm-so-hard-podcast-an-emergency-medicine-and-hospital-pharmacy-podcast/id1479624416","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png","title":null},{"name":"Podbean App","link":"https://www.podbean.com/pw/pbblog-j9fca-114a750?from=usersite","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/367btSv26kqQ2Ra1RA09mf","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/KkWyqbhYAfpw","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-GNW7m1SMGSe7","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"All rights reserved"},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[{"id":"ComponentImageText-1","val":{"ComponentFontColor":"#000000","ComponentBackgroundColor":"#f2f2f2","ComponentImage":"https://mcdn.podbean.com/mf/web/j2pwxh/PharmSoHard_Logo-037a54f9f3-7a34-aaf5-ebc0-4d9423e18164.png","ComponentContent":"

Pharm So Hard Podcast

The Pharm So Hard Podcast is a show focused primarily on emergency medicine and hospital pharmacy related topics. Episodes range from 5-30 minutes depending on the topic and guest speakers. The goal is to disseminate information in bite-sized episodes from experts in the field of acute care and hospital pharmacy sub-specialties.

"}}]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.generic","app_store_id":1484287462,"app_name":"Podbean Biz Podcast App","scheme":"enterprise-podbean-com"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":false,"organizationName":"Pharm So Hard Network","organizationPageLink":"https://www.podbean.com/podcast-network/jimmyrqj2rytqmm"},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"userLikeCheckedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://jimmyrq.podbean.com","apiCommonParams":{"t":"686c5b2f","clientSignature":"53f72e8c2851bc1f5c280ca670ac3a70","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb22566268-v8t4k","episode":{"id":"pb22566268","idTag":"v8t4k","title":"Episode 2: Factor Xa Inhibitor Reversal Using Andexxa with Gary Peksa","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18130768/cf6675af42a3f4b28d5d167d727458dd_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog18130768/cf6675af42a3f4b28d5d167d727458dd_1200x628.jpg?s=7e68b6715c068b578f4ce8fe496afbb4&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18130768/cf6675af42a3f4b28d5d167d727458dd.jpg","previewContent":null,"content":"In the second episode of Pharm So Hard, Jimmy Pruitt, Pharm.D and Gary Peksa PharmD, BCPS discuss the pharmacology and reviews the management of hemorrhage caused by factor Xa inhibitors using coagulation factor Xa (recombinant), inactivated-zhzo or ANDEXXA.","publishTimestamp":1569542400,"duration":1330,"mediaUrl":"https://mcdn.podbean.com/mf/web/2v9q92/e_http___feeds_soundcloud_com_stream_679844873-pharmsohard-episode-2-factor-xa-inhibitor-reversal-using-andexxa-with-gary-peksa.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-v8t4k-158557c","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-v8t4k-158557c","transcriptUrl":null,"permalink":"/e/episode-2-factor-xa-inhibitor-reversal-using-andexxa-with-gary-peksa-1708263794/","downloadLink":"https://www.podbean.com/media/share/pb-v8t4k-158557c?download=1","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":72,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-v8t4k-158557c","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false,"userIdEncrypted":null,"userProfilePicture":null,"username":null,"isVerified":false,"loadUserInfo":false,"loginUrl":"https://www.podbean.com/site/user/login?return=https%253A%252F%252Fjimmyrq.podbean.com%252Fe%252Fepisode-2-factor-xa-inhibitor-reversal-using-andexxa-with-gary-peksa-1708263794%252F&rts=03371d7680ef173b21a7dd234e7432b62adc6c22","recaptchaV3Loaded":false,"recaptchaV2Loaded":false,"likesLoaded":false,"commentLikeMap":{},"commentOffset":0},"episode":{"id":"pb22566268","idTag":"v8t4k","title":"Episode 2: Factor Xa Inhibitor Reversal Using Andexxa with Gary Peksa","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18130768/cf6675af42a3f4b28d5d167d727458dd_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog18130768/cf6675af42a3f4b28d5d167d727458dd_1200x628.jpg?s=7e68b6715c068b578f4ce8fe496afbb4&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18130768/cf6675af42a3f4b28d5d167d727458dd.jpg","previewContent":null,"content":"In the second episode of Pharm So Hard, Jimmy Pruitt, Pharm.D and Gary Peksa PharmD, BCPS discuss the pharmacology and reviews the management of hemorrhage caused by factor Xa inhibitors using coagulation factor Xa (recombinant), inactivated-zhzo or ANDEXXA.","publishTimestamp":1569542400,"duration":1330,"mediaUrl":"https://mcdn.podbean.com/mf/web/2v9q92/e_http___feeds_soundcloud_com_stream_679844873-pharmsohard-episode-2-factor-xa-inhibitor-reversal-using-andexxa-with-gary-peksa.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-v8t4k-158557c","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-v8t4k-158557c","transcriptUrl":null,"permalink":"/e/episode-2-factor-xa-inhibitor-reversal-using-andexxa-with-gary-peksa-1708263794/","downloadLink":"https://www.podbean.com/media/share/pb-v8t4k-158557c?download=1","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":72,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"loginUrl":"https://www.podbean.com/site/user/login?return=https%253A%252F%252Fjimmyrq.podbean.com%252Fe%252Fepisode-2-factor-xa-inhibitor-reversal-using-andexxa-with-gary-peksa-1708263794%252F&rts=03371d7680ef173b21a7dd234e7432b62adc6c22"}